David M. Goldstein
Directeur Technique/Scientifique/R&D chez PRINCIPIA BIOPHARMA INC.
Postes actifs de David M. Goldstein
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PRINCIPIA BIOPHARMA INC. | Directeur Technique/Scientifique/R&D | 01/01/2016 | - |
Frontier Medicines Corp.
 Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | Directeur/Membre du Conseil | 30/03/2021 | - |
Historique de carrière de David M. Goldstein
Anciens postes connus de David M. Goldstein
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/01/1994 | 01/01/2011 |
| Stanford University | Corporate Officer/Principal | - | - |
Formation de David M. Goldstein
| Franklin & Marshall College | Undergraduate Degree |
| University of Virginia | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| Suisse | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| Entreprise privées | 2 |
|---|---|
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Principia Biopharma, Inc. is a biopharmaceutical company, which engages in designing and developing oral therapies to patients with significant unmet medical needs in immunology and oncology. It operates through Tailored Covalency platform, which enables to develop small molecule inhibitors of enzymes and receptor ligands with potencies and selectivities that rival those of injectable biologics, yet maintain the convenience of a pill. Its product pipeline includes PRN1008, PRN2246, PRN1371, and immunoproteasome inhibitor. The company was founded by Jack Taunton and Richard A. Miller on October 6, 2008 and is headquartered in South San Francisco, CA. | Health Technology |
Frontier Medicines Corp.
Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | Health Technology |
- Bourse
- Insiders
- David M. Goldstein
- Expérience
